MedTrace Logo

A Study to Evaluate the Safety and Efficacy of a New Silicone Hydrogel Contact Lens Design

NCT01449526 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 166

Last updated 2015-02-18

Study results available
· View outcomes & findings →

Summary

The objective of this study is to evaluate the safety and efficacy of a new silicone hydrogel contact lens compared to the Bausch + Lomb PureVision contact lens when worn by adapted soft contact lens wearers.

Conditions

  • Myopia

Interventions

DEVICE

B&L Investigational Contact Lens

Lenses will be worn on a daily wear basis for 3 months, new lenses dispensed monthly.

DEVICE

B&L PureVision Contact Lens

Lenses will be worn on a daily wear basis for 3 months, new lenses dispensed monthly.

Sponsors & Collaborators

  • Bausch & Lomb Incorporated

    lead INDUSTRY

Principal Investigators

  • Robert Steffen, OD, MS · Bausch & Lomb Incorporated

Study Design

Allocation
RANDOMIZED
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-08-31
Primary Completion
2011-12-31
Completion
2012-01-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01449526 on ClinicalTrials.gov